Free Trial

Wellington Management Group LLP Raises Position in Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background
Remove Ads

Wellington Management Group LLP boosted its position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 7.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,632,232 shares of the company's stock after acquiring an additional 181,073 shares during the period. Wellington Management Group LLP owned about 4.81% of Molina Healthcare worth $766,111,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. State Street Corp lifted its stake in Molina Healthcare by 0.5% during the third quarter. State Street Corp now owns 2,614,311 shares of the company's stock worth $900,787,000 after purchasing an additional 13,001 shares during the last quarter. Norges Bank purchased a new position in shares of Molina Healthcare during the fourth quarter worth approximately $134,675,000. Charles Schwab Investment Management Inc. raised its position in Molina Healthcare by 2.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 400,080 shares of the company's stock valued at $116,443,000 after purchasing an additional 10,002 shares during the last quarter. Los Angeles Capital Management LLC raised its holdings in shares of Molina Healthcare by 166.1% in the fourth quarter. Los Angeles Capital Management LLC now owns 196,513 shares of the company's stock valued at $57,195,000 after buying an additional 122,674 shares during the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. lifted its position in Molina Healthcare by 2.2% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 149,573 shares of the company's stock worth $43,533,000 after acquiring an additional 3,238 shares during the period. 98.50% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Molina Healthcare Trading Up 0.2 %

MOH traded up $0.56 during midday trading on Wednesday, hitting $328.27. The company's stock had a trading volume of 384,080 shares, compared to its average volume of 634,557. Molina Healthcare, Inc. has a 52-week low of $262.32 and a 52-week high of $384.35. The firm has a 50-day moving average price of $304.95 and a two-hundred day moving average price of $308.51. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69. The firm has a market cap of $17.96 billion, a P/E ratio of 16.07, a PEG ratio of 1.06 and a beta of 0.56.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. On average, research analysts anticipate that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the transaction, the director now directly owns 17,375 shares of the company's stock, valued at $5,235,608.75. The trade was a 5.44 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 1.10% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Stephens restated an "equal weight" rating and set a $345.00 price objective on shares of Molina Healthcare in a research report on Thursday, February 6th. Truist Financial decreased their price objective on shares of Molina Healthcare from $370.00 to $340.00 and set a "buy" rating on the stock in a report on Wednesday, February 19th. JPMorgan Chase & Co. restated a "neutral" rating and issued a $350.00 price target (down previously from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. Mizuho reduced their price objective on Molina Healthcare from $382.00 to $376.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. Finally, Barclays lowered their target price on Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating on the stock in a report on Friday, February 7th. Six research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $348.75.

Read Our Latest Research Report on Molina Healthcare

About Molina Healthcare

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Read More

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Is Micron on Par with AMD? BUY Now or DEAD Money?

Is Micron on Par with AMD? BUY Now or DEAD Money?

Is the dip in Micron's stock price a golden buying opportunity or another case of dead money? MarketBeat's Thomas Hughes weighs in, comparing Micron to AMD.

Recent Videos

Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads